United States Securities and Exchange Commission
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: February 2, 2007
(Date of earliest event reported: February 1, 2007)
ONCOLOGIX TECH INC.
(Exact name of registrant as specified in its charter)
Nevada 001-15482 86-1006416
--------------------------- ---------- -----------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2850 Thornhills Ave., S.E., Suite 104
Grand Rapids, Michigan 49546
-------------------------------------- --------
(Address of principal executive offices) (Zip Code)
(616) 977-9933
-----------------------------
(Registrant's telephone number)
Check the appropriate box below if the Form 8-K is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On January 31, 2007 the registrant published a Press Release describing the
accomplishment of the first "milestone" in the development of its Oncosphere
product. Pursuant to the terms of its Merger Agreement with JDA Medical
Technologies, Inc. the attainment of that milestone fulfilled the condition for
the release from escrow of 7,460,792 shares of the Registrant's common stock to
the four holders thereof, who were principal shareholders of JDA, among whom the
following individuals are currently officers or directors of the Registrant:
Andrew Green, Andrew S. Kennedy, MD, and Adam Lowe.
Item 9.01 Financial Statements and Exhibits
(a) Exhibits
--------
Exhibit Title
99 Press release issued by Oncologix Tech Inc. dated
February 1, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BestNet Communications Corporation
By: /s/ Stanley L. Schloz
--------------------------------
Stanley L. Schloz
President
By: /s/ Michael A. Kramarz
--------------------------------
Michael A. Kramarz
Chief Financial Officer
Date: February 2, 2007